- Home
- LVTX vs BLAC Comparison
LVTX vs BLAC Comparison
Compare LVTX & BLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- BLAC
- Stock Information
- Founded
- LVTX 2016
- BLAC 2020
- Country
- LVTX Netherlands
- BLAC United States
- Employees
- LVTX N/A
- BLAC N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- BLAC
- Sector
- LVTX Health Care
- BLAC
- Exchange
- LVTX Nasdaq
- BLAC NYSE
- Market Cap
- LVTX 40.2M
- BLAC 44.6M
- IPO Year
- LVTX 2021
- BLAC 2023
- Fundamental
- Price
- LVTX $1.48
- BLAC $11.62
- Analyst Decision
- LVTX Strong Buy
- BLAC
- Analyst Count
- LVTX 2
- BLAC 0
- Target Price
- LVTX $6.00
- BLAC N/A
- AVG Volume (30 Days)
- LVTX 56.8K
- BLAC 5.8K
- Earning Date
- LVTX 12-03-2024
- BLAC 01-01-0001
- Dividend Yield
- LVTX N/A
- BLAC N/A
- EPS Growth
- LVTX N/A
- BLAC N/A
- EPS
- LVTX N/A
- BLAC N/A
- Revenue
- LVTX $7,398,000.00
- BLAC N/A
- Revenue This Year
- LVTX N/A
- BLAC N/A
- Revenue Next Year
- LVTX N/A
- BLAC N/A
- P/E Ratio
- LVTX N/A
- BLAC N/A
- Revenue Growth
- LVTX N/A
- BLAC N/A
- 52 Week Low
- LVTX $1.35
- BLAC $10.43
- 52 Week High
- LVTX $6.47
- BLAC $13.40
- Technical
- Relative Strength Index (RSI)
- LVTX 35.08
- BLAC 59.49
- Support Level
- LVTX $1.54
- BLAC $11.57
- Resistance Level
- LVTX $1.65
- BLAC $12.96
- Average True Range (ATR)
- LVTX 0.11
- BLAC 0.46
- MACD
- LVTX -0.04
- BLAC 0.05
- Stochastic Oscillator
- LVTX 3.92
- BLAC 25.52
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.
About BLAC BELLEVUE LIFE SCIENCES ACQ CORP
Bellevue Life Sciences Acquisition Corp is a blank check company.